Recent publications COVID-19 in south ENP countries EMCDDA risk assessment guidelines Low-THC cannabis products in Europe EMCDDA technical report on the new psychoactive substance 4F-MDMB-BICA EMCDDA technical report on the new psychoactive substance MDMB-4en-PINACA New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic Reitox national focal points’ activities during the COVID-19 pandemic edr-2020-carousel.jpg European Drug Report 2020: a comprehensive overview of the drug situation in Europe emcdda-25-years-carousel.png This year, the EMCDDA is celebrating 25 years of monitoring the drug situation in Europe (1995-2020) carousel-covid-19-and-drugs.jpg Access our resources on COVID-19 and drugs edmr-carousel-2.1-to-2-v2.jpg Download our state-of-the art overview of the European illicit drug market. test-your-knowledge-carousel-v2.jpg Can you separate the facts from the myths? Take our quiz about overdose and naloxone and find out. Latest news EMCDDA releases study findings on the impact of COVID-19 in the southern ENP region 22.12.2020 New report explores open sale of low-THC cannabis products and regulatory responses in Europe 21.12.2020 Season’s greetings and warm wishes for a safe and healthy 2021 18.12.2020 Cannabidiol (CBD) is not considered a ‘narcotic drug’ under European law 16.12.2020 EMCDDA signs new agreement with Serbia 15.12.2020 EMCDDA Best practice portal update (4/2020) 14.12.2020 Events European Drug Prevention Prize 2021 (deadline for applications) Fri 15 Jan European Drugs Winter School (EDWS) Mon 1 Mar to Fri 12 Mar Online European Drugs Summer School (EDSS) Mon 28 Jun to Fri 9 Jul Lisbon Featured publications European Drug Report: Trends and Developments (English) European Drug Report: Key Issues (24 languages) EU Drug Markets Report Drugs in syringes from six European cities Recent changes in Europe’s cocaine market Medical use of cannabis and cannabinoids Wastewater analysis and drugs — a European multi-city study Drugs and the darknet Health and social responses to drug problems: a European guide Recent videos EMCDDA Voices: Alexis Goosdeel 25 years of monitoring: highlights of the year EMCDDA Voices: Linda Montanari EMCDDA Voices: Duarte Loreto EMCDDA Voice: Gregor Burkhart EMCDDA Voices: Marica Ferri Data visualisations 25 years of prevention in Europe Interactive: wastewater analysis and drugs Infographic: Number of presentations to Euro-DEN Plus centres, 2017 Location of Euro-DEN Plus centres - update 31 December 2019 Infographic: new psychoactive substances (NPS) overview — substances reported to the EU Early Warning System since 1997 Map: location of sites related to MDMA production in the EU, 2015-17 Infographic: EU retail drug market size minimum estimate (2017) Map: location of sites related to methamphetamine production in the EU, 2015-17 Infographic: key impacts and consequences of drug markets Explore emcdda.europa.eu Data — all of the latest data and statistics on the drug situation Countries — national and country-specific information Topics (A-Z) — information and resources organised by topic Our activities — information on the EMCDDA's ongoing scientific work and projects Best practice portal — what works in different areas of drug-related interventions Publications — all of the EMCDDA's publications at your fingertips News and events — the latest news and an overview of key events in the drugs calendar About — information about the EMCDDA and its activities Spotlight 25 years of monitoring (1995-2020) Health and social responses to drug problems: a European guide
